Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |